← Back to Search

Other

High Salt for Cardiovascular Risk

N/A
Waitlist Available
Led By Shannon L Lennon, PhD, RD
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up on day 10
Awards & highlights

Study Summary

This trial will study the effects of high dietary salt intake on gut microbiota composition in men and women.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~on day 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and on day 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gut microbiota diversity
T cell profile

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: High SaltExperimental Treatment1 Intervention
Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with pills containing salt to achieve an intake of 6,900 mg/d sodium.
Group II: Recommended SaltPlacebo Group1 Intervention
Subjects will be counseled to consume a diet with 2,300 mg/d sodium which they will supplement with placebo pills.

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,180 Total Patients Enrolled
7 Trials studying Cardiovascular Risk
367 Patients Enrolled for Cardiovascular Risk
Shannon L Lennon, PhD, RDPrincipal InvestigatorUniversity of Delaware

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025